In addition, they suggest that: i) a number of disturbances arising from ATM mutation or deficiency (e.g., A‐T and different cancer types) could partly result from deficits in GSNOR‐mediated mitophagy; ii) increasing cellular denitrosylating capacity can represent a good tool to complement ATM in such diseases. This evidence concerns the gene ATM and cancer.